p27 as a Transcriptional Regulator: New Roles in Development and Cancer

Seyedeh Fatemeh Razavipour1, Kuzhuvelil B Harikumar2, Joyce M Slingerland3

  • 1Breast Cancer Program, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington DC.

Cancer Research
|April 29, 2020
PubMed

Insights

The protein p27, encoded by CDKN1B, regulates cell cycle, migration, and gene expression. Its noncanonical functions, particularly transcriptional regulation, are crucial in cancer development and progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The protein p27 (encoded by CDKN1B) is known to inhibit cyclin-CDK complexes, arresting cell cycle progression.
  • p27 also influences cell migration and development independently of its cell cycle inhibitory role.
  • CDKN1B mutations are rare in cancers, suggesting complex roles for p27 beyond tumor suppression.

Purpose of the Study:

  • To review the noncanonical, cyclin-dependent kinase (CDK)-independent functions of p27.
  • To emphasize the role of p27 in transcriptional regulation and its implications in cancer.
  • To explore how p27's interaction with transcription factors like cJun drives oncogenic pathways.

Main Methods:

  • Literature review focusing on CDK-independent functions of p27.
  • Analysis of recent data on p27's role in transcription and gene expression.
  • Examination of p27's phosphorylation-dependent interactions and their impact on cellular processes.

Main Results:

  • p27 acts as a transcriptional coregulator, notably with cJun.
  • C-terminal phosphorylation of p27 enhances its interaction with cJun, promoting oncogenic pathways.
  • Phosphorylated p27 can repress differentiation programs and drive cancer progression.
  • p27's noncanonical functions in migration, invasion, and gene expression are critical in cancer.

Conclusions:

  • p27 exhibits dual roles in cancer, acting as both a tumor suppressor and an oncogene.
  • Transcriptional regulation by p27, particularly its interaction with cJun, is a key mechanism in cancer.
  • Understanding p27-associated transcriptional complexes may reveal new therapeutic targets for cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K